zolpidem has been researched along with Long QT Syndrome in 5 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zolpidem, a short-acting hypnotic drug prescribed to treat insomnia, has been clinically associated with acquired long QT syndrome (LQTS) and torsade de pointes (TdP) tachyarrhythmia." | 7.79 | Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells. ( Becker, R; Deschenes, I; Ficker, E; Jehle, J; Katus, HA; Kisselbach, J; Schmidt, C; Schweizer, PA; Staudacher, I; Thomas, D; Wan, X; Wiedmann, F, 2013) |
| "Zolpidem, a short-acting hypnotic drug prescribed to treat insomnia, has been clinically associated with acquired long QT syndrome (LQTS) and torsade de pointes (TdP) tachyarrhythmia." | 3.79 | Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells. ( Becker, R; Deschenes, I; Ficker, E; Jehle, J; Katus, HA; Kisselbach, J; Schmidt, C; Schweizer, PA; Staudacher, I; Thomas, D; Wan, X; Wiedmann, F, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HJ | 1 |
| Jeong, WJ | 1 |
| Kim, KJ | 1 |
| Kim, SC | 1 |
| Kim, DW | 1 |
| Chang, HJ | 1 |
| Kang, CS | 1 |
| Oh, SK | 1 |
| Cho, SU | 1 |
| Min, JH | 1 |
| Cho, YC | 1 |
| Park, JS | 1 |
| Ryu, S | 1 |
| You, YH | 1 |
| Lee, JW | 1 |
| Kim, MS | 1 |
| Suarez, L | 1 |
| Kolla, BP | 1 |
| Hall-Flavin, D | 1 |
| Mansukhani, MP | 1 |
| Jehle, J | 1 |
| Ficker, E | 1 |
| Wan, X | 1 |
| Deschenes, I | 1 |
| Kisselbach, J | 1 |
| Wiedmann, F | 1 |
| Staudacher, I | 1 |
| Schmidt, C | 1 |
| Schweizer, PA | 1 |
| Becker, R | 1 |
| Katus, HA | 1 |
| Thomas, D | 1 |
| Letsas, KP | 1 |
| Filippatos, GS | 1 |
| Kounas, SP | 1 |
| Efremidis, M | 1 |
| Sideris, A | 1 |
| Kardaras, F | 1 |
| Somberg, J | 1 |
| Molnar, J | 1 |
5 other studies available for zolpidem and Long QT Syndrome
| Article | Year |
|---|---|
Serial plasma and urine measurements of a patient with acute intoxication of zolpidem and flunitrazepam resulting in QT prolongation and ventricular tachycardia.
Topics: Aged; Electrocardiography; Female; Flunitrazepam; Humans; Long QT Syndrome; Poisoning; Tachycardia, | 2020 |
QTc Prolongation Secondary to Zolpidem Use.
Topics: Aged; Female; Humans; Long QT Syndrome; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance | 2020 |
Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
Topics: Action Potentials; Animals; Cells, Cultured; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; | 2013 |
QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Electric Countershock; Female; Heart Co | 2006 |
Letter from Konstantinos P. Letsas et al. - invited editorial comment.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Humans; Hypnotics and Sedatives; Long QT Synd | 2006 |